# Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

> **NCT06511947** · PHASE1 · RECRUITING · sponsor: **GH Research Ireland Limited** · enrollment: 52 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** 5 Methoxy N,N Dimethyltryptamine

## Key facts

- **NCT ID:** NCT06511947
- **Lead sponsor:** GH Research Ireland Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511947, "Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06511947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*